GE Healthcare and Valneva : new delivery for Vaccine Production
GE Healthcare and Valneva Collaboration Delivers Optimized Cell Culture Medium for Vaccine Production + Collaboration jointly developed a new medium optimized... View Article
Florence Hallouin is appointed Deputy Director of Atlanpole Biotherapies Cluster
Florence HALLOUIN is appointed Deputy Director of Atlanpole Biotherapies. She ensures the operational coordination of the Cluster, relationships with its partners... View Article
CESTI IHU: innovative strategies of tolerance induction in the transplanted patient
This research program, led by Dr. Sophie Conchon (CRTI – Inserm 1064 – ITUN) uses the specific immunological properties of... View Article
Affilogic signs with Takeda global pharma
Takeda and Affilogic entered into a research collaboration to develop therapies based on Nanofitines® in the central nervous system …... View Article
ARRONAX PLUS: NEW TOOLS TO ENRICH THE NUCLEAR ARSENAL AGAINST CANCER
The objective in nuclear medicine (imaging and therapy) is to build up both a world-class research group and eventually... View Article
BIOREGATE FORUM: A GREAT SUCCESS!
In September in Nantes, an International Forum dedicated to regenerative medicine was held, bringing together 180 participants. Based on the... View Article
Horama raises €4 million with Omnes Capital, Sham Innovation Santé and GO Capital
Horama raises €4 million with Omnes Capital, Sham Innovation Santé and GO Capital Proceeds from this fundraising will be used to:... View Article
OSE Immunotherapeutics : exercise of option within global license agreement with Janssen
OSE Immunotherapeutics announces exercise of option within global license agreement with Janssen for further clinical development of FR104 and potential commercialisation... View Article
OGD2 Pharma and Green Cross LabCell start collaboration
OGD2 Pharma and Green Cross LabCell start collaboration for developing NKcell therapeutics targeting the O-acetyl-GD2 cancer antigen Nantes France & Seoul... View Article
Affilogic enters into a Research Collaboration and Licensing Agreement with Sanofi on Nanofitin-conjugated biotherapeutics
Affilogic announces the signature of a collaboration and license agreement with Sanofi for the development of Nanofitin®-conjugated biotherapeutics. Nantes –... View Article